Corebridge (CRBG) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Zacks Zacks에서 열기
Corebridge (CRBG) Reports Q1 Earnings: What Key Metrics Have to Say

Corebridge Financial (CRBG) reported $4.09 billion in revenue for the quarter ended March 2026, representing a year-over-year decline of 13.8%. EPS of $1.05 for the same period compares to $1.16 a year ago.

The reported revenue represents a surprise of -14.18% over the Zacks Consensus Estimate of $4.76 billion. With the consensus EPS estimate being $1.07, the EPS surprise was -1.43%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Corebridge performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Premiums: $387 million versus $1.12 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -56.5% change. Total Corebridge- Advisory fee and other income: $106 million versus the four-analyst average estimate of $102.51 million. The reported number represents a year-over-year change of -48.5%. Policy fees: $594 million versus $616.86 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -17.5% change. Total Corebridge- Net investment income: $2.99 billion versus $3.03 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +2.8% change. Revenue- Life Insurance: $1.04 billion versus the three-analyst average estimate of $1.06 billion. The reported number represents a year-over-year change of +0.1%. Revenue- Individual Retirement: $1.63 billion versus the three-analyst average estimate of $1.68 billion. The reported number represents a year-over-year change of -10.6%. Revenue- Corporate & Other: $14 million versus the three-analyst average estimate of $30.73 million. The reported number represents a year-over-year change of -74.1%. Revenue- Individual Retirement- Premiums: $16 million compared to the $26.38 million average estimate based on three analysts. The reported number represents a change of -40.7% year over year. Revenue- Individual Retirement- Policy fees: $77 million versus the three-analyst average estimate of $85.15 million. The reported number represents a year-over-year change of -61.1%. Revenue- Individual Retirement- Net investment income: $1.54 billion versus the three-analyst average estimate of $1.56 billion. The reported number represents a year-over-year change of +3.3%. Revenue- Group Retirement- Premiums: $1 million versus the three-analyst average estimate of $3.92 million. The reported number represents a year-over-year change of -75%. Revenue- Group Retirement- Policy fees: $109 million versus $112.03 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +0.9% change.

View all Key Company Metrics for Corebridge here>>>

Shares of Corebridge have returned +14.6% over the past month versus the Zacks S&P 500 composite's +10% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Corebridge Financial, Inc. (CRBG): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research